Background There is little consensus regarding the prevalence and distribution of
underlying systemic diseases among patients with pyoderma gangrenosum. Objective The …

Objective The aim of this study was to describe the clinical characteristics of patients with
pyoderma gangrenosum (PG) and to evaluate the association between these …

Pyoderma gangrenosum (PG) is an important disease with significant complications. The
objectives of this study were to determine incidence and mortality of PG and strength of …

Pyoderma gangrenosum is an uncommon ulcerative neutrophilic dermatosis. Clinical
presentation, location and associated diseases are diverse. Treatment of pyoderma …

Background Whether the underlying disease affects the outcomes in pyoderma
gangrenosum (PG) is unclear. Objectives To determine the impact of comorbid disease …

Background Pyoderma gangrenosum (PG) is an uncommon and challenging disease,
highly associated with comorbidities, but poorly characterized from a diagnostic and …

Because the incidence of pyoderma gangrenosum (PG) is low, no prospective randomized
controlled trials and only a few studies with case numbers of more than 15 patients have …

Abstract Introduction/Objectives Pyoderma gangrenosum (PG) is a rare, rapidly progressive
neutrophilic dermatosis commonly associated with systemic inflammatory diseases. We …

Background: Pyoderma gangrenosum (PG) is an idiopathic ulcerative neutrophilic
inflammatory skin disease characterized by variable clinical presentation and outcome …

526 F. Patel et al. of the disease usually requires long-term maintenance therapy to prevent
relapses from occurring. Although Brunsting and coworkers were incorrect in proposing an …